Since so many of you have been asking about the Reclast, and Zometa infusions, I thought I would post the New England Journal of Medicine's article on Zoledronic Acid (Reclast), the once yearly infusion for post menopausal osteoporotic patients.
The article is pretty straight forward and should be easy to read. I hope this helps many in answering your questions on side effects, benefits, etc.
This drug has been on the market for 5 years but primarily used for bone cancer patients, those with hypercalcemia and Paget's disease.
http://content.nejm.org/cgi/content/full/356/18/1809
Brand Names of this drug:
- Zometa
- Reclast
- Aclasta
- Zometa Concentrate



Add to the discussion